Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Single dose tocilizumab for COVID-19 associated cytokine storm syndrome: Less is more.
Boone NW, Moes DJAR, Ramiro S, Mostard RLM, Magro-Checa C, van Dongen CMP, Gronenschild M, van Haren E, Buijs J, de Vries A, Peeters R, Landewé RBM, Wong DR. Boone NW, et al. Among authors: mostard rlm. Br J Clin Pharmacol. 2023 Feb 15. doi: 10.1111/bcp.15690. Online ahead of print. Br J Clin Pharmacol. 2023. PMID: 36791777 Free article.
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study.
Ramiro S, Mostard RLM, Magro-Checa C, van Dongen CMP, Dormans T, Buijs J, Gronenschild M, de Kruif MD, van Haren EHJ, van Kraaij T, Leers MPG, Peeters R, Wong DR, Landewé RBM. Ramiro S, et al. Among authors: mostard rlm. Ann Rheum Dis. 2020 Sep;79(9):1143-1151. doi: 10.1136/annrheumdis-2020-218479. Epub 2020 Jul 20. Ann Rheum Dis. 2020. PMID: 32719045 Free PMC article. Clinical Trial.
Outcomes of persons with coronavirus disease 2019 in hospitals with and without standard treatment with (hydroxy)chloroquine.
Peters EJ, Collard D, Van Assen S, Beudel M, Bomers MK, Buijs J, De Haan LR, De Ruijter W, Douma RA, Elbers PW, Goorhuis A, Gritters van den Oever NC, Knarren LG, Moeniralam HS, Mostard RL, Quanjel MJ, Reidinga AC, Renckens R, Van Den Bergh JP, Vlasveld IN, Sikkens JJ; CovidPredict Study Group. Peters EJ, et al. Clin Microbiol Infect. 2021 Feb;27(2):264-268. doi: 10.1016/j.cmi.2020.10.004. Epub 2020 Oct 14. Clin Microbiol Infect. 2021. PMID: 33068758 Free PMC article.
Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study'' by Calvo-Aranda et al.
Ramiro S, Mostard R, Landewé RB. Ramiro S, et al. Ann Rheum Dis. 2023 Feb;82(2):e35. doi: 10.1136/annrheumdis-2020-219534. Epub 2020 Dec 14. Ann Rheum Dis. 2023. PMID: 33318060 No abstract available.
[Mortality and re-admission after hospitalization with COVID-19].
Leijte WT, Wagemaker NMM, van Kraaij TDA, de Kruif MD, Mostard GJM, Leers MPG, Mostard RLM, Buijs J, van Twist DJL. Leijte WT, et al. Among authors: mostard rlm, mostard gjm. Ned Tijdschr Geneeskd. 2020 Nov 19;164:D5423. Ned Tijdschr Geneeskd. 2020. PMID: 33332036 Dutch.
Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzer.
Martens RJH, van Adrichem AJ, Mattheij NJA, Brouwer CG, van Twist DJL, Broerse JJCR, Magro-Checa C, van Dongen CMP, Mostard RLM, Ramiro S, Landewé RBM, Leers MPG. Martens RJH, et al. Among authors: mostard rlm. Clin Chem Lab Med. 2020 Dec 9;59(4):783-793. doi: 10.1515/cclm-2020-1529. Print 2021 Mar 26. Clin Chem Lab Med. 2020. PMID: 33554540 Free article.
59 results